Related by context. All words. (Click for frequent words.) 76 analyst Jonathan Aschoff 76 analyst Jim Reddoch 73 Geoffrey Meacham 72 Eric Ende 72 analyst Geoffrey Meacham 72 Geoffrey Porges 71 Geoff Porges 71 Joseph Pantginis 71 Dr. Jim Birchenough 71 analyst Cory Kasimov 70 Jim Reddoch 70 Bret Holley 70 analyst Jim Birchenough 70 Akhtar Samad 70 Gbola Amusa 69 David Amsellem 69 Bert Hazlett 69 Joshua Schimmer 69 analyst Mark Schoenebaum 68 analyst Jami Rubin 68 Mark Monane 68 Chris Shibutani 67 Annabel Samimy 67 Moussatos 67 Mark Schoenebaum 67 analyst Yaron Werber 67 analyst Mark Monane 67 Geoff Meacham 67 Cory Kasimov 66 Monane 66 analyst Randall Stanicky 66 Edward Tenthoff 66 Jason Kantor 66 Ian Somaiya 66 Yaron Werber 66 Jason Kolbert 65 Steven Harr 65 Pantginis 65 Jim Birchenough 65 Jon LeCroy 65 Jason Gurda 65 Liana Moussatos 65 analyst Lawrence Keusch 65 Kochnover 65 Phil Nalbone 64 analyst Glenn Novarro 64 Larry Biegelsen 64 Jami Rubin 64 analyst Robert Cihra 64 Dr. Yaron Werber 63 Jonathan Aschoff 63 analyst Sapna Srivastava 63 Ken Cacciatore 63 analyst Simos Simeonidis 63 Kin Ho 63 Ronny Gal 63 Dr. Joshua Schimmer 63 analyst Maged Shenouda 63 analyst Amit Hazan 62 Funtleyder 62 Tenthoff 62 Sara Michelmore 62 analyst Geoffrey Porges 62 Lazard Capital 62 George Grofik 61 Sam Fazeli 61 analyst Liana Moussatos 61 Jeffrey Frelick 61 reaffirmed Outperform rating 61 analyst Seamus Fernandez 61 Betsy Van Hees 61 analyst Bruce Nudell 61 Bruce Nudell 61 analyst Ken Trbovich 61 Bruce Cranna 60 Andreas Theisen 60 Elan Tysabri 60 Eric Coldwell 60 Andrew Vaino 60 analyst Ajit Pai 60 Tao Levy 60 Rajesh Ghai 60 Jon Lecroy 60 Olav Zilian 60 Liisa Bayko 60 Kalpesh Kapadia 60 MyVax 60 analyst Joanne Wuensch 60 NASDAQ ACOR 60 Piper Jaffray PJC 60 Ziopharm 60 analyst Gbola Amusa 60 Randall Stanicky 59 Dhulsini de Zoysa 59 NASDAQ REGN 59 Seamus Fernandez 59 Matt Miksic 59 analyst Randal Konik 59 Scott Mushkin 59 Seattle Genetics SGEN 59 drug Treanda 59 analyst Rommel Dionisio 59 Daniel Berenbaum 59 Jerry Doctrow 59 Grofik 59 Curagen 59 Alexandra Hauber 59 Raj Denhoy 59 analyst Tore Svanberg 59 midstage clinical 59 Gary Nachman 59 Stanicky 59 Joel Fishbein 59 Celgene Revlimid 58 analyst Elemer Piros 58 analyst Raj Denhoy 58 Martin Possienke 58 Glenn Novarro 58 Amylin Eli Lilly 58 analyst Frank Mitsch 58 Medivation Inc 58 Krystexxa 58 ONXX 58 Cantor Fitzgerald reiterates 58 analyst Alexandra Hauber 58 Vertex VRTX 58 Michael Krensavage 58 MOGN 58 analyst Tony Wible 58 analyst Gurinder Kalra 58 BWS Financial 58 ZGEN 58 John DiFucci 58 Schoenebaum 58 Celgene Corp. 58 Lawrence Biegelsen 58 Tad Piper 58 Cubist Pharma 58 analyst Larry Biegelsen 58 NASDAQ IMGN 58 Damien Conover 58 Holger Blum 58 Dificid 58 Auxilium Pharma 57 analyst Charles Grom 57 Amgen Vectibix 57 WR Hambrecht reiterate 57 reaffirmed Neutral 57 Roopesh Patel 57 Leerink Swan 57 analyst Glenn Reicin 57 United Therapeutics UTHR 57 Biegelsen 57 Simos Simeonidis 57 Joe Pantginis 57 Dendreon Provenge 57 Lauren Cooks Levitan 57 Neely Tamminga 57 Lawrence Keusch 57 Saftlas 57 Sparlon 57 James Kumpel 57 Darren Lehrich 57 Satya Chillara 57 Sepracor SEPR 57 Molowa 57 Ariad Pharmaceuticals 57 analyst Youssef Squali 57 analyst George Grofik 57 Timothy Arcuri 57 Ulrich Huwald 57 David Molowa 57 analyst Bruce Cranna 57 Mike Krensavage 57 Trevor Polischuk 57 Kristine Koerber 57 Corcept Therapeutics 57 Kemp Dolliver 57 exenatide LAR 57 Tolamba 57 Scott Geels 57 David Hochstim 57 Quynh Pham 57 Underweight rating 57 SUPG 57 analyst Kristine Koerber 57 Forest Labs FRX 57 John Calcagnini 57 analyst Tim Klasell 57 analyst Bijan Moazami 57 Rachael Rothman 57 Gemzar gemcitabine 56 Glenn Reicin 56 Dynavax Technologies 56 Helene Wolk 56 Ken Trbovich 56 analyst Adrianne Shapira 56 analyst Hari Sambasivam 56 Cinquil 56 motesanib 56 Celgene CELG 56 Neibor 56 analyst Charles Boorady 56 NV1FGF 56 Barton Crockett 56 Nicholas Aberle 56 Vijay Rakesh 56 Gralise 56 Deane Dray 56 Velcade bortezomib 56 Recothrom 56 Vertex hepatitis C 56 Onyx Pharma 56 John Heinbockel 56 Bifeprunox 56 Affymax AFFY 56 Amylin AMLN 56 analyst Amit Bhalla 56 Keay Nakae 56 Gilead GILD 56 Celgene NASDAQ CELG 56 Xenoport 56 James Manuso 56 Remi Barbier 56 Inc. NASDAQ ITMN 56 Imclone Systems Inc. 56 analyst Matthew Fassler 56 Sven Borho partner 56 Eyetech Pharmaceuticals Inc. 56 MethyPatch 56 Camilo Lyon 56 Analyst Cody Acree 56 ImClone Erbitux 56 Inc. NASDAQ ACOR 56 Adventrx 56 Vitaxin 56 Nasdaq QCOR 56 analyst Stephen Tusa 56 Syncria 56 analyst Bruce Harting 56 AMAG Pharma 56 Luuk van Beek 56 Amgen denosumab 56 Matt Nemer 56 generic Lovenox 55 analyst Jeff Fidacaro 55 Leerink 55 analyst Annabel Samimy 55 Glen Yeung 55 analyst Ananda Baruah 55 Taxotere chemotherapy 55 Sunesis Pharmaceuticals 55 Ananda Baruah 55 Genentech Herceptin 55 Randal Konik 55 DepoMed 55 AstraZeneca AZN.ISE 55 Zadaxin 55 Nuedexta 55 Oncogenex 55 analyst Sasa Zorovic 55 Carl Seiden 55 Optimer Pharmaceuticals 55 analyst Richard Fetyko 55 Ana Gupte 55 Intuniv 55 Karl Heinz Scheunemann 55 Ahmar Zaman 55 Ron Bentsur 55 AUXL 55 analyst Tim Savageaux 55 Isaac Ro 55 Oxigene 55 B. Nemeroff 55 Steven Alexopoulos 55 Biegelsen wrote 55 Folotyn 55 Atsushi Seki 55 Merck boceprevir 55 Idenix Pharmaceuticals Inc. 55 Peter Appert 55 Cyclacel Pharmaceuticals 55 Nathan Schneiderman 55 Thom Gunderson 55 OSI Pharma 55 analyst Christa Quarles 55 analyst Dara Mohsenian 55 MDVN 55 analyst Katherine Styponias 55 Squali 55 CE Unterberg 55 Chris Brendler 55 Luveris 55 Array BioPharma ARRY 55 TSRX 55 Gregory Drahuschak 55 Navdeep Jaikaria 55 analyst Anthony Noto 55 Adrienne Tennant 55 Bristol Myers BMY 55 ARQL 55 Hologic NASDAQ HOLX 55 NASDAQ QCOR 55 analyst Mark Lipacis 55 Regeneron Pharma 55 Aaron Reames 55 analyst Julio Quinteros 55 Starlix 55 CV Therapeutics CVTX 55 Nasdaq IDIX 55 Justin Hott 55 Arcalyst 55 Tristan Gerra 55 Simeonidis 55 IVGN 55 Millennium Velcade 54 Avanir 54 Arena Pharmaceuticals ARNA 54 INCY 54 Camvia 54 Sena Lund 54 Hamed Khorsand 54 analyst Gregory Melich 54 Recentin 54 Amylin Byetta 54 Armando Anido 54 analyst Shebly Seyrafi 54 reaffirmed Market Perform 54 Heplisav 54 BernsteinResearch 54 Colazal 54 Vicuron Pharmaceuticals 54 analyst Emme Kozloff 54 Michael Taiano 54 Richard Fetyko 54 Leerink Swann 54 CE Unterberg Towbin 54 Vpriv 54 analyst Margaret Mager 54 analyst Alan Bezoza 54 Atherogenics 54 analyst Albert Savastano 54 OSI Tarceva 54 Ton Gietman 54 analyst Lori Appelbaum 54 Trubion Pharmaceuticals TRBN 54 Gilead Sciences GILD 54 analyst Douglas Sipkin 54 Indiplon 54 Kiacta 54 Genzyme Nasdaq GENZ 54 Arranon 54 NASDAQ ONXX 54 Byetta LAR 54 Jonathan Ruykhaver 54 Vishal Shreedhar 54 Douglas Harned 54 Todd Raker 54 analyst Jonathan Schildkraut 54 Myriad Genetics Inc 54 Corlux 54 analyst Dan Wantrobski 54 blood thinner prasugrel 54 Dr. McHutchison 54 Claude Camire 54 Drew Fromkin President 54 approvability 54 Synta Pharmaceuticals 54 Joe Osha 54 Drew Brosseau 54 Joseph Foresi 54 analyst Robert Drbul 54 WR Hambrecht 54 Patrick Walravens 54 AstraZeneca Iressa 54 Equal Weight rating 54 IDIX 54 Claudia Shank Hueston 54 analyst Sterling Auty 54 Fampridine 54 analyst Matthew Borsch 54 ABX EGF 54 Roche Actemra 54 economist Tushar Poddar 54 Mark Bacurin 54 Sterling Auty 54 Mahesh Sanganeria 54 Sven Borho 54 Idenix Pharmaceuticals 54 Michael Turits 54 Valeant Pharmaceuticals NYSE VRX 54 Sanctura XR 54 Jesse Pichel 54 Scot Ciccarelli 54 Cephalon NASDAQ CEPH 54 Praecis 54 Fusilev 54 Suji De Silva 54 Maher Yaghi 54 ATHX 54 GILD GILD 54 inhibit KSP 54 analyst Moshe Orenbuch 54 Transkaryotic 54 analyst Uche Orji 54 Phillip Nalbone 54 Krensavage 54 Rob Cihra 54 Savvas Neophytou 54 Vertex Pharmaceuticals NASDAQ VRTX 54 Dendreon DNDN 54 Donald Fandetti 54 Nasdaq MEDI 54 Immunogen 54 ThinkEquity upgraded 54 PTK ZK 54 analyst Anthony Chukumba 54 JoAnne Feeney 54 Drew Matus 54 David Turkaly 54 Carsten Kunold 54 Richard Kugele 54 Canvaxin 54 Theo Kitz 53 D mab 53 analyst Mark Edelstone 53 Steven Kron 53 Tanona 53 analyst Ehud Gelblum 53 Inc. Nasdaq IMGN 53 VPHM 53 Bugatch 53 MannKind MNKD 53 Gilead Sciences nasdaq GILD 53 Prolor 53 Denhoy 53 analyst Dinesh Moorjani 53 Sanjiv Wadhwani 53 lumiliximab 53 Nasdaq SLXP 53 antibiotic Vancocin 53 Asentar 53 Tocosol Paclitaxel 53 PiperJaffray 53 David Begleiter 53 Viramidine 53 Aegerion 53 Linjeta 53 Charles DiBona 53 NASDAQ ALXN 53 Co BMY.N 53 Nektar Therapeutics NKTR 53 analyst Kimberly Greenberger 53 Biogen Idec Elan 53 NASDAQ SGEN 53 Douglas Sipkin 53 Tesofensine 53 Tom Cholnoky 53 Adentri 53 Sanganeria 53 Celgene 53 Piper Jaffray reiterates 53 Karl Heinz Koch 53 Charles Grom 53 Jeffrey Holford 53 Novo Nordisk NOVOb.CO 53 Metabasis Therapeutics 53 Andrew Kligerman 53 Reiterates Hold 53 analyst Phillip Nalbone 53 Daniel Junius 53 Isis Pharma 53 Scott Devitt 53 NASDAQ BMRN 53 Dr. LaMattina 53 analyst Robert Koort 53 Rhyee 53 analyst Ajay Jain 53 Nicole Onetto MD 53 Avonex interferon beta 1a 53 Cubist Pharmaceuticals Inc 53 Amevive 53 Genzyme NASDAQ GENZ 53 Allos Therapeutics Incorporated 53 analyst Alex Gauna 53 experimental lupus 53 Biogen IDEC 53 Helvea analyst Olav Zilian 53 analyst Gregory Badishkanian 53 Depomed DEPO 53 Brean Murray 53 ViroPharma VPHM 53 Vion Pharmaceuticals 53 Rod Bourgeois 53 analyst Rebecca Runkle 53 Gary Giblen 53 Advate 53 dalbavancin 53 ULTRAM ER 53 analyst Ashwin Shirvaikar 53 Mabthera 53 Krishna Shankar 53 Gilead Sciences Inc 53 Progenics Pharmaceuticals 53 MGI Pharma 53 Vertex Pharmaceuticals VRTX 53 Dominic Valder 53 Sensipar 53 Piper Jaffray downgraded 53 GENZ 53 Ziopharm Oncology Inc. 53 Fanapt iloperidone 53 Genzyme GENZ 53 Inc. NASDAQ CEPH 53 Vertex Pharma 53 Ardea Biosciences 53 Mark A. Sirgo 53 Penwest Pharmaceuticals 53 Jean Pierre Lehner 53 Matthew Borsch 53 OGXI 53 Human Genome Sciences HGSI 53 Joshua Raskin 53 Serono SRA 53 Andrew Parmentier 53 Avastin Herceptin 53 Philip Alling 53 Somatuline Depot 53 Robert Spingarn 53 Dendreon Corp 53 Muraglitazar 53 analyst Connie Maneaty 53 Gattex 53 spokesman Tony Plohoros 53 analyst Andrey Glukhov 53 Mark Swartzberg 53 Neutral Weight 53 Orencia abatacept 53 Steven Halper 53 MediGene focuses 53 Amgen anemia 53 Neuvenge 53 analyst Mehdi Hosseini 53 Nasdaq HGSI 53 analyst Steven Wieczynski 53 Christopher Danely 53 Promacta 53 analyst Jacques Rousseau 53 Groschke 53 Bob Drbul 53 paliperidone ER 53 Teva Pharmaceutical TEVA 53 ENZN 53 April Scee 53 Inc. NASDAQ HGSI 53 Maintains Overweight 53 Pfizer inhaled insulin 53 Drbul 53 PDE# inhibitors 53 Roche Mircera 53 Transkaryotic Therapies TKTX 53 Allergan NYSE AGN 53 Immucor BLUD 53 Genitope 53 Joshua Shanker 53 Rigel Pharmaceuticals 53 NASDAQ ENDP 53 GNLB 53 Scott Krasik 53 analyst Amit Daryanani 53 Co LLY.N 53 Xenoport Inc. 53 Genentech Roche Chugai 53 Genzyme Corp 53 Plovanic 52 Analyst Cai von 52 Ariad Pharma 52 Ingrid Chung 52 OPTR 52 Paul Mansky 52 William Tanona 52 analyst Colby Synesael 52 Marc Cluzel 52 MDCO 52 analyst Tal Liani 52 NASDAQ ARIA 52 Allos Therapeutics ALTH 52 NEUTRAL rating 52 anidulafungin 52 Roche RHHBY 52 Corp. MNKD 52 Geoff Ruddell 52 Vijay Jayant 52 SGEN 52 analyst Christopher Growe 52 BioMarin Pharmaceutical 52 Sanofi NYSE SNY 52 RW Baird analyst 52 Biocryst 52 Panitumumab 52 analyst Les Funtleyder 52 ZIOP 52 NASDAQ GPRO 52 iniparib 52 MedImmune MEDI 52 Lazard Capital Markets 52 Reddoch 52 THRX 52 Brent Thill 52 CLDX 52 Robert Lacoursiere 52 IMGN 52 BioMarin Pharma 52 MLNM 52 Optimer Pharma 52 muscle relaxant Amrix 52 NASDAQ VRTX 52 JMP Securities reiterate 52 PDL Biopharma 52 Nasdaq CBST 52 Anthony Gikas 52 Kevin Scotcher 52 Celgene nasdaq CELG 52 Levadex 52 exenatide Byetta 52 Stacy Rasgon 52 Æterna Zentaris 52 Vertex Pharmaceuticals Inc 52 Removab 52 Kenji Masuzoe 52 Tore Svanberg 52 OMRIX Biopharmaceuticals 52 Healthcare Tailwinds Conference 52 analyst Nigel Dally 52 analyst Adrienne Tennant 52 bosutinib 52 Nebido 52 Savient Pharmaceuticals SVNT 52 Eyetech Pharmaceuticals 52 Fibrillex 52 Acorda Therapeutics ACOR 52 Eyetech 52 Pulminiq 52 Biosante 52 Inhibitex INHX 52 SangStat 52 Aegerion Pharmaceuticals 52 Nasdaq AVNR 52 Polymeropoulos 52 Amylin Pharmaceuticals Inc 52 Dylan Cathers 52 bifeprunox 52 analyst Pablo Zuanic 52 analyst Mark Swartzberg 52 Cancidas 52 Salmedix 52 Benjamin Mogil 52 Biogen Idec Tysabri 52 IG HCR ;) CO 52 Lauren Silvernail 52 CytoGam 52 Intermune 52 Matthew Emmens 52 pneumonia vaccine Prevnar 52 NASDAQ INCY 52 Nasdaq IPXL 52 Vicuron 52 VNDA 52 Amylin Pharmaceuticals Nasdaq AMLN 52 Sanjay Shrestha 52 PHRM 52 Al Kaschalk 52 Colin Sebastian 52 analyst Randy Binner 52 analyst Guy Moszkowski 52 Arzerra 52 Ethyol 52 Vertex telaprevir 52 Novantrone 52 HuMax CD# 52 rituximab Rituxan 52 Encysive Pharmaceuticals 52 ThinkEquity LLC 52 Roche Holding AG RHHBY 52 DVAX 52 Horizant 52 Bristol Myers NYSE BMY 52 Aloprim 52 Michael Rehaut 52 Afrezza 52 Treanda 52 Muken 52 Piper Jaffray 52 Michael Masdea 52 ABGX 52 OSIP 52 Ben Mogil 52 Tobias Levkovich 52 Biogen Idec Inc 52 Synta Pharma 52 CLDA 52 Pharmasset VRUS 52 Novartis NVS 52 Kevin Buchi 52 Inc NGSX 52 CDP# 52 Amgen Prolia 52 Genentech Rituxan 52 Lipacis 52 Birgit Kulhoff 52 NRMX 52 NASDAQ HGSI 52 Inc. NASDAQ EVVV 52 Zalbin 52 analyst Maarten Altena 52 CRTX 52 Curtis Shauger 52 Exelixis Nasdaq EXEL 52 Avanir Pharmaceuticals 52 Reverset 52 Mark Astrachan 52 Auxilium Pharmaceuticals Inc 52 analyst Ross Muken 52 Cubicin 52 ThinkEquity 52 Nigel Dally 52 Dendreon Nasdaq DNDN 52 Brion Tanous 52 analyst Silke Stegemann 52 KERX 52 J. Fassler 52 Cypress Bioscience 52 Punk Ziegel 52 Impax Laboratories IPXL 52 NASDAQ ZIOP 52 Dorothy Lakner 52 Vanda Pharma 52 Protalix BioTherapeutics 52 SCRX 52 Abbott Niaspan 52 analyst Junaid Husain 52 DOV Pharmaceutical 51 analyst Elizabeth Osur 51 Targacept TRGT 51 Troy Lahr 51 Jeetil Patel 51 Submits Response 51 Panagiotis Spiliopoulos 51 Uplyso 51 Thomas Cholnoky 51 BPAX 51 CRXX 51 analyst Anna Torma 51 AVNR 51 Nps Pharmaceuticals Incorporated 51 analyst Walter Piecyk 51 Imclone Systems 51 Roger Perlmutter Amgen 51 FBPase 51 Dr. Gail Cawkwell 51 Viropharma 51 analyst Joseph Greff 51 Anton Wahlman 51 Biogen Idec nasdaq BIIB 51 FazaClo 51 Medarex MEDX 51 Frank Baldino Jr. 51 INVEGA ® 51 antibiotic Cubicin 51 Abbott ABT 51 SILENOR 51 Forest Laboratories FRX 51 generic Copaxone 51 Navid Malik 51 Robyn Karnauskas 51 Overweight rating 51 Piper Jaffray reiterate 51 John Janedis 51 Salix Pharma 51 Christa Quarles 51 Rigel Pharmaceuticals Inc. 51 Erika Maschmeyer 51 TolerRx 51 alemtuzumab Campath 51 analyst Antony Broadbent 51 MGI Pharma MOGN 51 analyst Ton Gietman 51 Jeffrey Klinefelter 51 Eli Lilly NYSE LLY 51 Genvec 51 ZymoGenetics ZGEN 51 Thomas Weisel 51 QCOR 51 PDLI 51 sulfonylurea metformin 51 Co BMY 51 Jerry Dellis 51 Onyx Pharmaceuticals ONXX 51 Alnara Pharmaceuticals 51 Alpharma ALO 51 Nasdaq MOGN 51 Mark G. Foletta 51 Raptiva efalizumab 51 Arxxant 51 Zybrestat 51 Incyte INCY 51 Financial XLF Bearish 51 BMY 51 analyst Rick Sherlund 51 analyst Lawrence Klatzkin 51 analyst William Pecoriello 51 SG Cowen 51 analyst Brad Reback 51 Schering SHR 51 NASDAQ SVNT 51 BMRN 51 Technosphere Insulin 51 Inc XNPT 51 Revlimid 51 Inc CEPH 51 Regeneron Pharmaceuticals REGN 51 Lilly Amylin 51 Inc. NASDAQ VVUS 51 gepirone ER 51 Jeff Wlodarczak 51 Vectibix panitumumab 51 Ajit Pai 51 analyst Kian Abouhossein 51 Michael Leuchten 51 NASDAQ SLXP 51 Lupuzor 51 Nasdaq REGN 51 Acorda Therapeutics NASDAQ ACOR 51 ticagrelor Brilinta 51 Nasdaq BIIB 51 Analyst Toni Sacconaghi 51 Robert Breza 51 Delcath Systems DCTH 51 analyst Laura Conigliaro 51 Thomas R. Wadewitz 51 Paul Laikind 51 Humira adalimumab 51 Zocor Zetia 51 Inspire Pharmaceuticals ISPH 51 Neely JN Tamminga 51 Roche ROG.VX 51 Matthew Heimermann 51 Nabi Biopharmaceuticals NABI 51 Stephen Volkmann 51 Andrew Speller 51 analyst Edwin Mok 51 SGMO 51 Cerovive 51 OSI Pharmaceuticals OSIP 51 Nicholas Landekic 51 analyst Donald Fandetti 51 Ittai Kidron 51 Biogen Elan 51 analyst Maynard Um 51 RF Micro Device 51 TroVax ® 51 James Janesky 51 ixabepilone 51 Ross Seymore 51 Barry D. Quart 51 analyst Greg Mesniaeff 51 experimental hepatitis C 51 Michael Vinciquerra 51 Combidex 51 Elan Biogen 51 RBC Capital Mkts Reiterate 51 Amylin Pharma 51 PDL BioPharma 51 Entereg 51 ONTAK 51 Inc. Nasdaq ARNA 51 analyst Hamed Khorsand 51 Plavix patent 51 Simponi golimumab 51 Miikana Therapeutics 51 chemopreventive agent 51 BioDelivery Sciences 51 FBR Capital NASDAQ FBCM 51 analyst Christopher Mutascio 51 Romit Shah 51 macitentan 51 Eurand NV EURX 51 Wedbush 51 Adam Feuerstein 51 Douglas Anmuth 51 Pat Walravens 51 analyst Betsy Graseck 51 Piper Jaffrey 51 Regeneron Pharmaceuticals NASDAQ REGN 51 Epivir 51 analyst Peter Misek 51 Anurag Rana 51 Rommel Dionisio 51 analyst Michael Rehaut 51 Katherine Egbert 51 Alnylam Nasdaq ALNY 51 Analyst Rebecca Arbogast 51 Lisnic 51 biosimilar versions 51 CR Bard BCR 51 Edward Najarian 51 Zekauskas 51 maribavir 51 analyst Joshua Shanker 51 fampridine SR 51 ThinkEquity Partners LLC 51 Cepheid NASDAQ CPHD 51 ALTH 51 Matthew Kather 51 Natixis Bleichroeder analyst 51 Nasdaq GPRO announced 51 analyst Brent Thill 51 marketperformer 51 Rexahn Pharmaceuticals 51 Regeneron Pharmaceuticals 51 EYET 51 analyst Vivek Arya 51 Enbrel etanercept 51 Maintains Buy rating 51 Lazard Capital reiterate 51 Carl Pelzel 51 Vorapaxar 51 Nexium ulcer medicine 51 analyst Ghansham Panjabi 51 analyst Jeffrey Fidacaro 51 Biomarin 51 LGND 51 MYGN 51 Dynavax Technologies Corp. 51 NASDAQ OMER 51 Kos Pharmaceuticals KOSP 51 Paul Cuddon 51 Wellbutrin SR 51 Jonathan Dorsheimer 51 NASDAQ PGNX 51 SUSTENNA TM 51 NASDAQ ALTH 51 Isis Pharmaceuticals ISIS 51 Maintains Neutral 51 Phil Skolnick 51 HGSI 51 Aryx 51 Idenix Pharma 51 Biomarin Pharm 51 analyst Deane Dray 51 MBRX 51 NASDAQ IPXL 51 NGSX 51 Sav Neophytou 51 Matthew DiFrisco 51 Jay Gelb 51 Maintains Hold 51 Georges Gemayel 51 Cougar Biotechnology 51 Egrifta 51 Ricky Goldwasser 51 CytoFab 51 Regeneron REGN 51 Durect 51 Preos 51 Genzyme Corp GENZ.O 51 PGxPredict tests 51 Ironwood Pharmaceuticals Inc. 51 NASDAQ MNKD 51 ThinkEquity downgraded 51 Suneet Kamath 51 analyst Michael Exstein 51 analyst Louis Miscioscia 51 Robert Cihra 51 NASDAQ AKRX 51 Genelabs Technologies 51 Threshold Pharmaceuticals Inc. 51 Bruce Harting 51 Sipkin 51 Inc CYBX 51 CVTX 51 Nasdaq VRTX 51 Matt DiFrisco 51 Steven Winoker 51 ISPH 51 Orencia 51 Exelixis EXEL 51 VitiGam TM 51 Jeff Klinefelter 51 Edwards Lifesciences EW 51 Resumes Coverage 51 GTOP 51 ALXN 50 Questcor Pharmaceuticals QCOR 50 Flamel Technologies Nasdaq FLML 50 Aberman 50 Kash Rangan 50 Osiris Therapeutics 50 TRACON Pharmaceuticals